Practice Update: Diabetes

Features

21 Dr Peter L ibby on New Territory in Targeting Triglycerides 22 My Appro ach to the Elderly Patient with Resistant Hypertension

Conference

coverage

American Diabetes Association Scientific Sessions 2017 8 The PCSK9 Inhibitor Alirocumab Reduces LDL and Non-HDL Cholesterol in Insulin-Dependent Patients with Type 2 Diabetes 9 SGLT2 Inhibitors are Associated with Reduced Cardiovascular Disease in Patients with Type 2 Diabetes 10 Hybrid Closed-Loop Systems Prove Safe and Effective in Controlling Glucose Levels in Children and Adults with Type 2 Diabetes 11 The PCSK9 Inhibitor Alirocumab Reduces Non-HDL Cholesterol in Patients with Type 2 Diabetes and Mixed Dyslipidaemia 12 Autoantigen GAD Vaccine is Safe for Children at High Risk of Type 1 Diabetes 13 New, Ultra-Long- Acting Insulin Degludec Demonstrates Cardiovascular Safety and Reduces Risk of Severe Hypoglycemia 14 Long-Term Metformin Treatment Found to Reduce Risk of Heart Disease in Adults with Type 1 Diabetes

Cover

Improved Diet Quality

Associated with

Reduced Mortality

RESEARCH

Editor’s picks

4 Improved Diet Quality Associated with Reduced Mortality 5 Canagliflozin May Reduce Cardiovascular Events in Type 2 Diabetes 6 Glycemic Control Reduces Risk of Coronary Events in Men With Type 1 Diabetes 7 Higher Two-Hour Post- Load Glucose Predicts Risk for Cardiovascular Events in CAD

Microvascular

complications

15 Effects Of Empagliflozin on the Urinary Albumin-to- Creatinine Ratio in Patients with Type 2 Diabetes and Established CVD

Diabetes

16 High Prevalence of Diabetic Peripheral Neuropathy Found in Young People with Diabetes 17 Glucose Self-Monitoring in Non-Insulin Treated Patients with Type 2 Diabetes Does Not Improve Glycemic Control

Cardiovascular

complications

18 Differential Effects of Dapagliflozin on Cardiovascular Risk Factors at Varying Degrees of Renal Function 19 With Aspirin and Statin Use, Diabetics Without CAD Have Same Risk for MI as Non-Diabetics

Obesity

20 Physical Activity Alters Genetic Susceptibility to Long-Term Weight Gain

PracticeUpdate

is guided by a world-renowned

Editorial and Advisory Board that represents

community practitioners and academic specialists

with cross-disciplinary expertise.

Editor-in-Chief

Silvio Inzucchi MD

Associate Editors

Richard Pratley MD,

Deborah Wexler MD

Editorial Contributors

Lisa Parikh,

Ana Perdigoto MDPhD,

Camille Powe MD

PracticeUpdate® is a registered trademark of Elsevier

ABOUT

PracticeUpdate Diabetes

provides coverage of key

research from leading international conferences, and

a collection of top journal articles and accompanying

expert commentaries in a convenient print periodical.

These and more are also available online at www.

practiceupdate.com

PracticeUpdate and

PracticeUpdate Diabetes

are commercially supported by advertising,

sponsorship, and educational grants. Individual access

to PracticeUpdate.com is free. Premium content is

available to any user who registers with the site.

While PracticeUpdate is a commercially-sponsored

product, it maintains the highest level of academic

rigour, objectivity, and fair balance associated with all

Elsevier products. No editorial content is influenced

in any way by commercial sponsors or content

contributors.

DISCLAIMER

PracticeUpdate Diabetes

has been developed

for specialist medical professionals. The ideas

and opinions expressed in this publication do not

necessarily reflect those of the Publisher. Elsevier will

not assume responsibility for damages, loss, or claims

of any kind arising from or related to the information

contained in this publication, including any claims

related to the products, drugs, or services mentioned

herein. Because of rapid advances in the medical

sciences, in particular, independent verification

of diagnoses and drug dosages should be made.

Please consult the full current Product Information

before prescribing any medication mentioned in this

publication.

Although all advertising material is expected to

conform to ethical (medical) standards, inclusion in

this publication does not constitute a guarantee or

endorsement of the quality or value of such product or

of the claims made of it by its manufacturer.

SALES

Fleur Gill

fleur.gill@elsevier.com

Linnea Mitchell-Taverner

l.mitchell@elsevier.com

PRODUCTION

Editorial Manager

Anne Neilson

anne.neilson@elsevier.com

Editorial Project Manager

Carolyn Ng

Designer

Jana Sokolovskaja

PracticeUpdate Diabetes

published by Elsevier Australia

ISSN 2208-1488 (Print) ISSN 2208-1496 (Online)

ABN 70 001 002 357

475 Victoria Avenue

Chatswood NSW 2067 Australia

Locked Bag 7500 Chatswood DC NSW 2067

EMED081701

CONTENTS

VOL. 1 • NO. 2 • 2017